UNM's third quarter of 2026 marks a pivotal moment in the company's ongoing effort to de-risk its balance sheet. The quarter's results were heavily shaped by the planned Fortitude Re reinsurance transaction, a multi-billion-dollar arrangement designed to transfer a large portion of the company's long-term care liabilities and free up capital for its core disability, life, and supplemental health businesses. For investors, the report offers a clear test of whether the company's simplified business model can sustain profitability and premium growth even as the headline income statement absorbs substantial one-time charges. Prior quarters showed solid sales growth and strong persistency, so this release is being read primarily for signals about underlying underwriting margins, claims trends, and the durability of management's capital-return strategy.
UNM swung to a net loss of $419.7 million, or $2.65 per diluted share, in the third quarter of 2026, versus net income of $39.7 million, or $0.23 per share, in the same period a year earlier. The loss largely reflected an $853 million net investment loss, primarily impairment charges associated with the planned Fortitude Re long-term care reinsurance transaction. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Total revenue declined 21.6% year over year to $2.55 billion, down from $3.38 billion, as the prior-year period included a $128 million investment gain that reversed into the substantial investment loss this quarter. Premium income, however, increased 4.2% to $2.80 billion, and net investment income rose to $522.4 million from $476.8 million a year earlier.
On an adjusted basis, which excludes investment gains and losses and other non-operating items, after-tax adjusted operating income was $349 million, or $2.20 per diluted share, compared with $479.4 million, or $2.81 per share, a year earlier. This result came in roughly in line with Wall Street consensus estimates near $2.17 to $2.18 per share, even as the GAAP (Generally Accepted Accounting Principles) loss of $2.65 per share fell far short of analyst projections. Book value per common share stood at $68.90.
Management also updated its full-year outlook, now expecting 2026 after-tax adjusted operating income of $8.30 to $8.50 per share, a range that includes approximately $0.33 per share from a notable reserve-related item and represents a modest reduction from the prior guidance of $8.60 to $8.90 per share.
In the immediate aftermath of the release, UNM shares declined about 5.5% to roughly $86, according to early trading data, as the sizable GAAP loss captured investor attention even though core operating trends remained broadly steady. The sharp year-over-year decline in revenue and the swing to a loss were largely attributable to non-operating items tied to the Fortitude Re transaction, but the reduced full-year earnings guidance also weighed on sentiment.
Investor interpretation centered on the distinction between the company's headline results and its adjusted operating performance. The beat on net premiums earned and the roughly in-line adjusted operating EPS suggested underlying demand and pricing remained intact, while the lower guidance range and elevated claims activity in group disability emerged as key concerns heading into the fourth quarter.
Looking ahead, investors will be watching whether UNM's core segments can maintain premium growth and underwriting discipline now that a substantial portion of its long-term care exposure is being transferred. The company's revised full-year adjusted operating EPS guidance of $8.30 to $8.50 sets a concrete benchmark for the fourth quarter, and management's commentary on the earnings call will be scrutinized for any further changes to that outlook.
Claims trends in the group disability business are a central risk factor. The quarter reflected elevated claim submissions in certain lines, and any sustained deterioration in the benefit ratio could pressure margins across the Unum US segment. Persistency rates, which measure customer retention, will also matter, given their direct influence on future premium income.
Capital deployment remains another area of focus. With a $1 billion share repurchase program in place and a quarterly dividend of $0.505 per share, investors will monitor how management balances returning capital to shareholders against maintaining strong risk-based capital and holding company liquidity following the reinsurance transaction. The completion and final accounting of the Fortitude Re deal will be a key catalyst, as it should clarify the company's long-term earnings power and capital flexibility.
In my research process, I often rely on Tickeron’s AI Screener to quickly filter insurance stocks and compare fundamentals like premium growth and adjusted earnings against peers. This tool lets me scan for patterns in volatility and performance metrics, helping confirm whether UNM's underlying trends align with broader sector signals before drawing conclusions from the quarter.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
UNM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 30 cases where UNM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 33 of 50 cases where UNM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 66%.
Following a +1.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where UNM advanced for three days, in 254 of 359 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UNM as a result. In 29 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 33%.
The Moving Average Convergence Divergence Histogram (MACD) for UNM turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 23 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 43%.
UNM moved below its 50-day moving average on October 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for UNM crossed bearishly below the 50-day moving average on October 27, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 41%.
The Aroon Indicator for UNM entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. UNM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.333) is normal, around the industry mean (1.339). P/E Ratio (21.069) is within average values for comparable stocks, (19.974). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (0.463). Dividend Yield (0.022) settles around the average of (0.047) among similar stocks. P/S Ratio (1.187) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of long-term and short-term disability insurance, group life and accidental death and dismemberment products
Industry LifeHealthInsurance